Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights

Acta Oncologica

Volumn 52, Issue 3, 2013, Pages 627-635

  Hompland, Tord ^a   Gulliksrud, Kristine ^a   Ellingsen, Christine ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOMELITOL; P846; UNCLASSIFIED DRUG; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MEASUREMENT; MELANOMA; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; TISSUE PRESSURE; TUMOR XENOGRAFT; ANIMAL EXPERIMENT; BLOOD SAMPLING; CURVE FITTING; DRUG DISTRIBUTION; NEOPLASM; NON INVASIVE PROCEDURE;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; EXTRACELLULAR FLUID; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR WEIGHT; NEOPLASMS; PRESSURE; SKIN NEOPLASMS;

EID: 84875180194     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.737931     Document Type: Article

References (30)

1. Lunt SJ, Fyles A, Hill RP, Milosevic M. Interstitial fluid pressure in tumors: Therapeutic barrier and biomarker of angiogenesis. Future Oncol 2008;4:793-802
2. Heldin CH, Rubin K, Pietras K, Östman A. High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer 2004;4:806-13 (Pubitemid 39331152)
3. Rofstad EK, Gaustad JV, Brurberg KG, Mathiesen B, Galappathi K, Simonsen TG. Radiocurability is associated with interstitial fluid pressure in human tumor xenografts. Neoplasia 2009;11:1243-51
4. Rofstad EK, Ruud EBM, Mathiesen B, Galappathi K. Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue. Clin Cancer Res 2010;16:936-45
5. Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, Nilsen K, et al. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 2002;62:661-4 (Pubitemid 34126937)
6. Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 2001;61:6400-5 (Pubitemid 32783245)
7. Fyles A, Milosevic M, Pintilie M, Syed A, Levin W, Manchul L, et al. Long-term performance of interstitial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol 2006;80:132-7 (Pubitemid 44314013)
8. Yeo SG, Kim JS, Cho MJ, Kim KH, Kim JS. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy. Clin Cancer Res 2009;15:6201-7
9. Jain RK. Delivery of molecular medicine to solid tumors. Science 1996;271:1079-80 (Pubitemid 26075221)
10. Milosevic M, Fyles A, Hill RP. The relationship between elevated interstitial fluid pressure and blood flow in tumors: A bioengineering analysis. Int J Radiat Oncol Biol Phys 1999;43:1111-23 (Pubitemid 29144802)
11. Haider MA, Sitartchouk I, Roberts TPL, Fyles A, Hashmi AT, Milosevic M. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. J Magn Reson Imaging 2007;25:153-9 (Pubitemid 46095210)
12. Yankeelov TE, Gore JC. Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2009;3:91-107 (Pubitemid 46773870)
13. Henderson E, Sykes J, Drost D, Weinmann HJ, Rutt BK, Lee TY. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. J Magn Reson Imaging 2000;12:991-1003
14. de Lussanet QG, Langereis S, Beets-Tan RGH, van Genderen MHP, Griffioen AW, van Engelshoven JMA, et al. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. Radiology 2005;235: 65-72 (Pubitemid 40432238)
15. Donaldson SB, Betts G, Bonington SC, Homer JJ, Slevin NJ, Kershaw LE, et al. Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates Figure 5. Median Ktrans versus IFP for A-07 tumors imaged with P846 for ∼4 min (a), ∼7 min (b), or ∼10 min (c). The points represent individual tumors, and the solid curves were fitted to the data by linear regression analysis. The dashed curves represent the 95% confidence intervals. inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: A pilot study. Int J Radiat Oncol Biol Phys 2011;81:1176-83
16. Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution DCE-MRI: A preclinical study of human melanoma xenografts. Magn Reson Med 2004;52:269-76 (Pubitemid 39025270)
17. Egeland TAM, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images. Radiat Res 2009;172:339-47
18. Gulliksrud K, Brurberg KG, Rofstad EK. Dynamic contrastenhanced magnetic resonance imaging of tumor interstitial fluid pressure. Radiother Oncol 2009;91:107-13
19. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32 (Pubitemid 29463104)
20. Rofstad EK. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br J Cancer 1994;70:804-12 (Pubitemid 24331069)
21. Delrue LJ, Casneuf V, Van Damme N, Blanckaert P, Peeters M, Ceelen WP, et al. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights. Magn Reson Mater Phys 2011;24:225-32
22. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-71 (Pubitemid 24129954)
23. Ozerdem U, Hargens AR. A simple method for measuring interstitial fluid pressure in cancer tissues. Microvasc Res 2005;70:116-20 (Pubitemid 41565417)
24. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ. High resolution pHe imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med 2006;55:309-15 (Pubitemid 43238099)
25. Michoux N, Huwart L, Abarca-Quinones J, Dorvillius M, Annet L, Peeters F, et al. Transvascular and interstitial transport in rat hepatocellular carcinomas: Dynamic contrastenhanced MRI assessment with low- and high-molecular weight agents. J Magn Reson Imaging 2008;28:906-14
26. Cao Y, Li D, Shen Z, Normolle D. Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters. Acad Radiol 2010;17:468-78
27. Ewing JR, Brown SL, Lu M, Panda S, Ding G, Knight RA, et al. Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor. J Cereb Blood Flow Metab 2006;26:310-20
28. Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011;66:735-45
29. Graff BA, Benjaminsen IC, Brurberg KG, Ruud EBM, Rofstad EK. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. J Magn Reson Imaging 2005;21:272-81 (Pubitemid 40280122)
30. Ellingsen C, Øvrebø KM, Galappathi K, Mathiesen B, Rofstad EK. The pO2 fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts. Int J Radiat Oncol Biol Phys 2012;83:1317-23